JNDOF
Price
$22.75
Change
-$3.25 (-12.50%)
Updated
Oct 13 closing price
Capitalization
1.28B
SRTOY
Price
$21.22
Change
+$0.01 (+0.05%)
Updated
Aug 13 closing price
Capitalization
20.17B
Interact to see
Advertisement

JNDOF vs SRTOY

Header iconJNDOF vs SRTOY Comparison
Open Charts JNDOF vs SRTOYBanner chart's image
Jins
Price$22.75
Change-$3.25 (-12.50%)
Volume$300
Capitalization1.28B
Sartorius Stedim Biotech
Price$21.22
Change+$0.01 (+0.05%)
Volume$465
Capitalization20.17B
JNDOF vs SRTOY Comparison Chart in %
Loading...
SRTOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JNDOF vs. SRTOY commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNDOF is a Hold and SRTOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (JNDOF: $22.75 vs. SRTOY: $21.22)
Brand notoriety: JNDOF and SRTOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: JNDOF: 100% vs. SRTOY: 81%
Market capitalization -- JNDOF: $1.28B vs. SRTOY: $20.17B
JNDOF [@Pharmaceuticals: Other] is valued at $1.28B. SRTOY’s [@Pharmaceuticals: Other] market capitalization is $20.17B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNDOF’s FA Score shows that 1 FA rating(s) are green whileSRTOY’s FA Score has 0 green FA rating(s).

  • JNDOF’s FA Score: 1 green, 4 red.
  • SRTOY’s FA Score: 0 green, 5 red.
According to our system of comparison, JNDOF is a better buy in the long-term than SRTOY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRTOY’s TA Score shows that 4 TA indicator(s) are bullish.

  • SRTOY’s TA Score: 4 bullish, 5 bearish.

Price Growth

JNDOF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while SRTOY (@Pharmaceuticals: Other) price change was +3.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.53%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +4.24%.

Industries' Descriptions

@Pharmaceuticals: Other (+0.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRTOY($20.2B) has a higher market cap than JNDOF($1.28B). SRTOY has higher P/E ratio than JNDOF: SRTOY (78.43) vs JNDOF (47.34). SRTOY YTD gains are higher at: 8.381 vs. JNDOF (0.000). JNDOF has higher annual earnings (EBITDA): 13.3B vs. SRTOY (740M). JNDOF has more cash in the bank: 11.4B vs. SRTOY (745M). SRTOY has less debt than JNDOF: SRTOY (2.97B) vs JNDOF (5.61B). JNDOF has higher revenues than SRTOY: JNDOF (89.8B) vs SRTOY (2.9B).
JNDOFSRTOYJNDOF / SRTOY
Capitalization1.28B20.2B6%
EBITDA13.3B740M1,797%
Gain YTD0.0008.381-
P/E Ratio47.3478.4360%
Revenue89.8B2.9B3,101%
Total Cash11.4B745M1,530%
Total Debt5.61B2.97B189%
FUNDAMENTALS RATINGS
JNDOF: Fundamental Ratings
JNDOF
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
61
PRICE GROWTH RATING
1..100
70
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JNDOFSRTOY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
65%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
59%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
53%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
6%
Bullish Trend 2 days ago
29%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
4%
Bearish Trend 2 days ago
55%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
64%
Declines
ODDS (%)
N/A
Bearish Trend 19 days ago
50%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
SRTOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PHK4.87N/A
N/A
PIMCO High Income Fund
CAFX24.96-0.02
-0.08%
Congress Intermediate Bond ETF
IEF95.23-0.19
-0.20%
iShares 7-10 Year Treasury Bond ETF
BFEB46.04-0.09
-0.20%
Innovator U.S. Equity Buffer ETF™ - Feb
XUSP44.14-0.21
-0.46%
Innovator Uncapped Accelerated US Eq ETF

JNDOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNDOF has been loosely correlated with OM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if JNDOF jumps, then OM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNDOF
1D Price
Change %
JNDOF100%
N/A
OM - JNDOF
40%
Loosely correlated
+3.10%
SDMHF - JNDOF
30%
Poorly correlated
N/A
SRTOY - JNDOF
22%
Poorly correlated
N/A
SOAGY - JNDOF
16%
Poorly correlated
-0.34%
FLMNY - JNDOF
13%
Poorly correlated
N/A
More

SRTOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRTOY has been loosely correlated with SOAGY. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTOY jumps, then SOAGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTOY
1D Price
Change %
SRTOY100%
N/A
SOAGY - SRTOY
48%
Loosely correlated
-0.34%
SDMHF - SRTOY
35%
Loosely correlated
N/A
SARTF - SRTOY
24%
Poorly correlated
N/A
BMXMF - SRTOY
24%
Poorly correlated
N/A
CHEOY - SRTOY
23%
Poorly correlated
+3.10%
More